NYC Pharmacy Fraud Defense Lawyer
Pharmacies and pharmacists in New York City face an increasingly aggressive federal enforcement environment targeting healthcare billing fraud, illegal kickback arrangements, and controlled substance diversion. Federal agencies including the Department of Health and Human Services Office of Inspector General (HHS-OIG), the Drug Enforcement Administration (DEA), and the FBI are actively investigating pharmacies across Manhattan, Brooklyn, Queens, and the surrounding boroughs for violations that carry severe criminal penalties. At Sosinsky Law, our
Manhattan healthcare fraud defense lawyer has more than 30 years of experience defending pharmacists, pharmacy owners, and pharmacy corporations against federal criminal charges in the Southern District of New York (SDNY) and the Eastern District of New York (EDNY).
Federal Criminal Charges Facing Pharmacies in New York
Pharmacies operate at the intersection of healthcare delivery and controlled substance distribution, which places them squarely within the jurisdiction of multiple federal enforcement agencies. A single pharmacy investigation can produce charges spanning healthcare fraud, anti-kickback violations, drug diversion, and conspiracy, each carrying substantial prison time and financial penalties.
The most common federal charges brought against pharmacies and pharmacists in New York include healthcare fraud under 18 U.S.C. Section 1347, which carries up to 10 years in federal prison per count and up to 20 years if the fraud results in serious bodily injury. Conspiracy to commit healthcare fraud under 18 U.S.C. Section 1349 carries the same penalties. Violations of the Federal Anti-Kickback Statute under 42 U.S.C. Section 1320a-7b carry up to 10 years imprisonment and fines of up to $100,000 per violation. And unlawful distribution of controlled substances under 21 U.S.C. Section 841 can trigger mandatory minimum sentences depending on the type and quantity of drugs involved.
Anti-Kickback Statute Violations and Pharmacy Operations
The Federal Anti-Kickback Statute (AKS) is one of the most significant sources of criminal exposure for pharmacies in New York. The statute prohibits anyone from knowingly and willfully offering, paying, soliciting, or receiving any form of remuneration to induce or reward referrals of patients or business payable by a federal healthcare program such as Medicare or Medicaid.
For pharmacies, kickback allegations frequently arise from arrangements with physicians or clinics that refer patients to a specific pharmacy in exchange for payments, gifts, or other benefits. Referral fee arrangements with patient recruiters, marketers, or brokers who steer patients to a pharmacy are also common targets. Providing free or below-cost goods and services to physicians or medical practices in exchange for prescription referrals can trigger AKS scrutiny, as can offering co-pay waivers or discounts to patients as an inducement to fill prescriptions at a particular location.
Federal prosecutors in New York treat kickback violations seriously because they view these arrangements as corrupting medical decision-making and inflating costs to federal healthcare programs. A conviction for an AKS violation results not only in criminal penalties but also mandatory exclusion from all federal healthcare programs, which effectively destroys a pharmacy’s ability to operate. Our
federal fraud defense lawyer understands how to challenge the government’s characterization of legitimate business relationships as illegal kickbacks.
Pharmacy Billing Fraud Schemes Targeted by Federal Prosecutors
Phantom Billing and Prescription Fraud
Federal investigators in New York aggressively pursue pharmacies suspected of billing Medicare, Medicaid, or private insurance for prescriptions that were never actually dispensed. These phantom billing schemes may involve submitting claims for medications that patients never received, billing for brand-name drugs while dispensing cheaper generics or no medication at all, and fabricating or altering prescriptions to create billable transactions. These cases are often built through data analytics that identify billing patterns inconsistent with patient populations, prescription volumes, or purchasing records. Our
Medicaid and Medicare fraud defense lawyer has extensive experience challenging the statistical models and audit methodologies federal investigators rely on in these cases.
Short-Filling and Partial Dispensing Fraud
Short-filling occurs when a pharmacy dispenses fewer pills or a smaller quantity of medication than what is billed to the insurance program. Federal investigators detect these schemes by comparing purchasing records from drug wholesalers against billing volumes submitted to Medicare and Medicaid. If a pharmacy is billing for significantly more medication than it is purchasing, the discrepancy provides strong evidence of fraud. In New York, these cases have resulted in multi-million dollar loss calculations that drive sentencing exposure well into the double-digit guideline range.
Compounding Pharmacy Fraud
Compounding pharmacies in New York have faced intense federal scrutiny in recent years. These pharmacies prepare customized medications for individual patients, and the higher reimbursement rates for compounded drugs create financial incentives that federal prosecutors allege drive fraudulent billing. Charges in compounding pharmacy cases often involve billing for expensive compounded medications when cheaper alternatives were available or appropriate, using unnecessary or excessively expensive ingredients to inflate reimbursement amounts, and paying kickbacks to physicians to prescribe compounded medications. These cases are complex and require a defense attorney who understands both the regulatory framework governing compounding pharmacies and the federal criminal statutes under which these allegations are prosecuted.
Controlled Substance Diversion
Pharmacists have a legal obligation to ensure that controlled substances are dispensed only pursuant to valid prescriptions issued for a legitimate medical purpose. When the DEA suspects that a pharmacy is filling prescriptions without proper verification or is knowingly dispensing controlled substances outside the bounds of legitimate medical practice, the consequences are severe. Our
NYC drug crime defense lawyer handles cases where pharmacists are accused of filling suspicious prescriptions without exercising their corresponding responsibility, dispensing controlled substances in quantities inconsistent with legitimate medical use, and operating as part of pill mill networks in coordination with prescribing physicians.
How Federal Pharmacy Fraud Investigations Unfold in New York
Federal pharmacy fraud investigations are typically long-running and multi-agency efforts. They often begin with data analysis by the Centers for Medicare and Medicaid Services (CMS) or HHS-OIG, which flag pharmacies with unusual billing patterns for further investigation. From there, federal agents may issue
grand jury subpoenas for pharmacy records, billing data, prescription logs, and financial documents. Agents may also use undercover operations, including sending individuals with fake or suspicious prescriptions to test whether a pharmacy will fill them without proper verification.
Cooperating witnesses are another critical tool in these investigations. Former employees, delivery drivers, patients, and even co-conspirators who have agreed to cooperate with the government in exchange for leniency can provide testimony that forms the backbone of the prosecution’s case. Challenging the credibility and motivations of cooperating witnesses is a central element of an effective defense strategy.
Consequences of a Federal Pharmacy Fraud Conviction
The penalties for a federal pharmacy fraud conviction extend far beyond imprisonment and fines. A pharmacist or pharmacy owner convicted of healthcare fraud or AKS violations faces mandatory exclusion from Medicare, Medicaid, and all other federal healthcare programs, which effectively prevents the pharmacy from operating. Professional licensing boards in New York will also initiate disciplinary proceedings that can result in the permanent revocation of a pharmacist’s license.
Additionally, federal forfeiture laws allow the government to seize assets acquired with proceeds of healthcare fraud, including the pharmacy itself, bank accounts, vehicles, and real estate. Civil penalties under the False Claims Act can impose treble damages and per-claim fines that reach into the millions. Our
federal sentencing advocacy lawyer works to protect our clients’ professional futures and personal assets while fighting for the most favorable possible outcome at every stage of the case.
Defense Strategies for Federal Pharmacy Fraud Charges
Every pharmacy fraud case is different, but effective defense strategies commonly include challenging whether the defendant had the requisite knowledge and intent to commit fraud, demonstrating that billing errors were the result of clerical mistakes or software issues rather than intentional fraud, disputing the government’s loss calculations which directly impact sentencing exposure, challenging the characterization of legitimate business arrangements as illegal kickbacks by demonstrating compliance with recognized AKS safe harbors, and attacking the reliability of cooperating witness testimony. Whether your case involves allegations in
Manhattan, Brooklyn, or anywhere in the New York metropolitan area, Sosinsky Law brings the depth of experience these high-stakes cases require.
Contact a New York City Pharmacy Fraud Defense Attorney
If you are a pharmacist, pharmacy owner, or pharmacy employee facing a federal investigation or criminal charges related to pharmacy fraud, kickback violations, or controlled substance diversion in New York, the consequences you face are career-ending and potentially life-altering. Contact Sosinsky Law at (212) 285-2270 for a free and confidential consultation. Attorney Fred Sosinsky has the experience and resources to defend your rights, your license, and your future.